retatrutide approval 2025 is the most significant weight-loss pharmaceutical currently in clinical development., Phase 3 TRIUMPH-4 trial results (published December 2025) showed average body weight reduction of People Are Already Taking This

Best Protein Sources for People on GLP-1 Medications When shopping for protein products, be cautious of foods marketed as high protein. Many contain only modest amounts of protein relative to their calories and are often overpriced or overhyped

This is the dosing trap

Similar to fruits, these should be eaten raw or very lightly steamed to maintain their antioxidant value

Increasing the number of intestinal endocrine L-cells According to the impairment of L-cells development in T2DM, a promising strategy for treating T2DM is to increase the number of L-cells in the intestine, thereby increasing the production of GLP-1